All Stories

  1. High-sensitivity Troponin (hs-Tn) for Cardiovascular Risk Prognostication: A Systematic Review and Meta-analysis
  2. MicroRNAs as Biomarkers in Hypertrophic Cardiomyopathy: Current State of the Art
  3. The Effect of DPP-4i on Endothelial Function and Arterial Stiffness in Patients with Type 2 Diabetes: A Systematic Review of Randomized Placebo-controlled Trials
  4. Novel Antidiabetic Agents: Cardiovascular and Safety Outcomes
  5. Pro-inflammatory Cytokines in Acute Coronary Syndromes
  6. Antithrombotic Therapy in Carotid Artery Disease
  7. Aortic regurgitation in competitive athletes: The role of multimodality imaging for clinical decision-making
  8. Associations between Adiponectin Gene Variability, Proinflammatory and Angiogenetic Markers: Implications for Microvascular Disease Development in Type 2 Diabetes Mellitus?
  9. Effects of Newer Antidiabetic Drugs on Endothelial Function and Arterial Stiffness: A Systematic Review and Meta-Analysis
  10. Long-term endothelial dysfunction after trans-radial catheterization: A meta-analytic approach
  11. Western Dietary Pattern Is Associated With Severe Coronary Artery Disease
  12. Redox State in Atrial Fibrillation Pathogenesis and Relevant Therapeutic Approaches
  13. Microangiopathy, Arterial Stiffness, and Risk Stratification in Patients With Type 2 Diabetes
  14. Macrovascular function indices for the prediction of diabetic retinopathy development in patients with type 2 diabetes
  15. Anesthetic ointment only (lidocaine/prilocaine) instead of injectable local lidocaine in trans-radial catheterization: A viable no-needle alternative
  16. The molecular mechanisms of obesity paradox
  17. Predictive value of telomere length on outcome following acute myocardial infarction: evidence for contrasting effects of vascular vs. blood oxidative stress
  18. The role of epicardial adipose tissue in cardiac biology: classic concepts and emerging roles
  19. A rare case of a flail tricuspid valve in a patient with pulmonary artery hypertension
  20. ASSOCIATION OF ENDOTHELIAL DYSFUNCTION WITH BIOMARKERS OF INFLAMMATION, MYOCARDIAL FIBROSIS AND LEFT VENTRICLE STRAIN IN PATIENTS WITH HEART FAILURE
  21. OMEGA-3 POLYUNSATURATED FATTY ACIDS MAY FAVORABLY AFFECT INFLAMMATORY BIOMARKERS & NOVEL INDICES OF LEFT VENTRICLE FUNCTION IN PATIENTS WITH HEART FAILURE
  22. ASSOCIATION OF ABDOMINAL AORTIC WALL INFLAMMATION, HEPATIC FLUORODEOXYGLUCOSE UPTAKE AND VISCERAL ADIPOSE TISSUE BIOLOGICAL ACTIVITY IN PATIENTS WITH DYSLIPIDEMIAS
  23. Reply to the letter to the editor “Survival after cardiac arrest in Greece”
  24. Prognostic implications of epicardial fat volume quantification in acute pericarditis
  25. Successful primary PCI during prolonged continuous cardiopulmonary resuscitation with an automated chest compression device (AutoPulse)
  26. The impact of T786C and G894T polymorphisms of eNOS on vascular endothelial growth factor serum levels in type 2 diabetes patients
  27. Effects of transradial coronary catheterization on systemic and local vascular endothelial function and inflammatory process
  28. Usefulness of C-Reactive Protein as a Predictor of Contrast-Induced Nephropathy After Percutaneous Coronary Interventions in Patients With Acute Myocardial Infarction and Presentation of a New Risk Score (Athens CIN Score)
  29. Peripheral and coronary artery embolisms due to left ventricle fibroelastoma
  30. From the BMI paradox to the obesity paradox: the obesity-mortality association in coronary heart disease
  31. Characterization of vascular phenotype in patients with coronary artery ectasia: The role of endothelial dysfunction
  32. THE ASSOCIATION OF REGIONAL INFLAMMATION OF THE AORTA ASSESSED BY 18F-FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY WITH SYSTEMIC INFLAMMATORY AND ECHOCARDIOGRAPHIC INDICES IN MARFAN SYNDROME
  33. Impairment of arterial elastic properties and elevated circulating levels of transforming growth factor-beta in subjects with repaired coarctation of aorta
  34. Nanomedicine in Cardiovascular Disease
  35. Mutual Regulation of Epicardial Adipose Tissue and Myocardial Redox State by PPAR-γ/Adiponectin SignallingNovelty and Significance
  36. The Impact of Interleukin-18 and High-Mobility Group Box 1 Protein Signaling in Aortic Valve Calcification
  37. Sinus arrest during citalopram treatment: Dose- or age-related?
  38. Unravelling the “adipokine paradox”: When the classic proatherogenic adipokine leptin is deemed the beneficial one
  39. Intercellular communication lessons in heart failure
  40. Arterial Wall Elastic Properties and Endothelial Dysfunction in the Diabetic Foot Syndrome in Patients With Type 2 Diabetes
  41. Pre-operative inflammation and post-operative atrial fibrillation in coronary artery bypass surgery
  42. Combined effects of fibrinogen genetic variability on atherosclerosis in patients with or without stable angina pectoris: Focus on the coagulation cascade and endothelial function
  43. Genetic variability on adiponectin gene affects myocardial infarction risk: The role of endothelial dysfunction
  44. Artifactual elevation of plasma sCD40L by residual platelets in patients with coronary artery disease
  45. The Role of Genetic Traits in Cardiovascular Disease
  46. CIRCULATING LEVELS OF PRO-INFLAMMATORY MEDIATORS PREDICT THE POSTOPERATIVE development of acute heart failure in patients undergoing elective coronary artery bypass grafting operation
  47. Statins as Anti-Inflammatory Agents in Atherogenesis: Molecular Mechanisms and Lessons from the Recent Clinical Trials
  48. NADPH-STIMULATED SUPEROXIDE AS A SENSITIVE MARKER OF CELLULAR OXIDATIVE STRESS: ITS VALUE AS A MARKER OF VASCULAR FUNCTION IN HUMAN ATHEROSCLEROSIS
  49. CHAPTER 3. Vitamins and Folate Fortification in the Context of Cardiovascular Disease Prevention
  50. CHAPTER 12. The Chemistry of Cobalamins
  51. Myocardial Redox State Predicts In-Hospital Clinical Outcome After Cardiac Surgery
  52. Adiponectin as a Regulator of Vascular Redox State: Therapeutic Implications
  53. THE IMPACT OF G174C POLYMORPHISM ON INTERLEUKIN-6 GENE IS ASSOCIATED WITH THE ONSET AGE IN PATIENTS WITH CORONARY ARTERY DISEASE
  54. LOCAL ADIPONECTIN SYNTHESIS IN ADIPOSE TISSUE REGULATES VASCULAR SUPEROXIDE GENERATION IN PATIENTS WITH CORONARY ATHEROSCLEROSIS: INSIGHTS BY USING FUNCTIONAL GENETIC POLYMORPHISMS OF ADIPONECTIN GENE
  55. RAPID, DIRECT EFFECTS OF STATIN TREATMENT ON ARTERIAL REDOX STATE AND NITRIC OXIDE BIOAVAILABILITY IN HUMAN ATHEROSCLEROSIS VIA TETRAHYDROBIOPTERIN-MEDIATED ENOS COUPLING
  56. THE IMPACT OF GENETIC VARIABILITY OF FIBRINOGEN A-CHAIN GENE DEFINES FIBRINOGEN LEVELS BETWEEN HEALTHY INDIVIDUALS AND PATIENTS WITH DOCUMENTED ATHEROSCLEROSIS: EFFECTS ON PROTHROMBOTIC PROFILE
  57. Obesity and cardiovascular disease: From pathophysiology to risk stratification
  58. The CD40/CD40 Ligand System
  59. A Rare Case of Primary Cardiac Lymphoma Presented as Superior Vena Cava Syndrome
  60. Relationship Between the Pharmacokinetics of Levosimendan and Its Effects on Cardiovascular System
  61. Targeting Redox Signaling in the Vascular Wall: From Basic Science to Clinical Practice